Table 1 Subject demographics, pathology, surgical profile and postsurgical phase.
From: Real-time observation of microcirculatory leukocytes in patients undergoing major liver resection
Patient demographics | Mean ± SD |
|---|---|
Age (years) | 61.3 ± 12.1 |
Weight (kg) | 73.5 ± 15 |
BMI (kg/m2) | 24.9 ± 4.3 |
Gender (male:female) | 11: 8 |
Co-morbidities | |
Smoker (Y:N) | 3: 16 |
COPD (Y:N) | 3: 16 |
Hypertension (Y N) | 9: 10 |
Diabetes (Y:N) | 3: 16 |
Pathology | |
Perihilar carcinoma (n) | 8 |
HCC (n) | 2 |
CRLM (n) | 2 |
Gallbladder carcinoma (n) | 1 |
Haemangioma (n) | 1 |
Intrahepatic cholangiocarcinoma (n) | 4 |
Biliary Ig4-related disease (n) | 1 |
Type of surgery | |
Left hemi-hepatectomy (n) | 4 |
Right hemi-hepatectomy (n) | 14 |
ALPPS 1st phase (n) | 1 |
Surgical characteristics | |
Surgical duration (mins) | 486 ± 121 |
Blood loss (mLs) | 1674 ± 875 |
VIO (n) | 1.4 ± 0.8 |
VIO duration (mins) | 33.5 ± 20 |
VIO applied (Y:N) | 16: 3 |
Postsurgical phase | |
24-h morbidity (Y:N) | 6: 13 |
30-day morbidity (Y:N) | 14: 5 |
Clavien–Dindo ≥ 3 within 30 days (Y:N) | 12: 7 |
Clavien–Dindo scoring within 30 days | |
Score 0 (number (%)) | 3 (16) |
Score 1 (number (%)) | 3 (16) |
Score 2 (number (%)) | 1 (5) |
Score 3 (number (%)) | 5 (26) |
Score 4 (number (%)) | 5 (26) |
Score 5 (number (%)) | 2 (11) |
30-day mortality (Y:N) | 2*: 17 |
